HUMAN TRIALS OF EXPERIMENTAL AIDS VACCINES

被引:46
作者
FAST, PE
WALKER, MC
机构
[1] Vaccine Research and Dev Branch, Division of AIDS NIAID NIH, Solar Building Room 2B-06, Bethesda, MD 20892
关键词
AIDS; HIV-1; HIV VACCINES; VACCINE CLINICAL TRIALS;
D O I
10.1097/00002030-199301001-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:S147 / S159
页数:13
相关论文
共 124 条
[1]  
ADA GL, 1989, FUNDAMENTAL IMMUNOLO, P985
[2]   THE EXPRESSION OF HYBRID HIV-TY VIRUS-LIKE PARTICLES IN YEAST [J].
ADAMS, SE ;
DAWSON, KM ;
GULL, K ;
KINGSMAN, SM ;
KINGSMAN, AJ .
NATURE, 1987, 329 (6134) :68-70
[3]  
AGGARWAL A, 1991, 8 INT C AIDS III STD
[4]   HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES TO LIVE RECOMBINANT BCG-HIV VACCINES [J].
ALDOVINI, A ;
YOUNG, RA .
NATURE, 1991, 351 (6326) :479-482
[5]   SUMMARY - ADJUVANTS CLINICAL-TRIALS WORKING GROUP [J].
ALVING, CR ;
GLASS, M ;
DETRICK, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (08) :1427-1430
[6]   LARGE-SCALE PRODUCTION AND PURIFICATION OF A VACCINIA RECOMBINANT-DERIVED HIV-1 GP160 AND ANALYSIS OF ITS IMMUNOGENICITY [J].
BARRETT, N ;
MITTERER, A ;
MUNDT, W ;
EIBL, J ;
EIBL, M ;
GALLO, RC ;
MOSS, B ;
DORNER, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (02) :159-171
[7]  
BELSHE R, 1992, 8 INT C AIDS III STD
[8]   A PREDOMINANT GROUP-SPECIFIC NEUTRALIZING EPITOPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MAPS TO RESIDUE-342 TO RESIDUE-511 OF THE ENVELOPE GLYCOPROTEIN-GP120 [J].
BERKOWER, I ;
MURPHY, D ;
SMITH, CC ;
SMITH, GE .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5983-5990
[9]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[10]  
BERMAN PW, 1992, J CELL BIOCH E S, V16, P15